Get the Stockscreener App
1.10
4.35%
-0.05
Pre-market:
1.07
-0.03
-2.73%
Standard Biotools Inc Stock (LAB) Latest News
STANDARD BIOTOOLS INC. SEC 10-K Report - TradingView
Rhumbline Advisers Sells 10,975 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Casdin Partners master fund buys $5.13 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Casdin Partners master fund buys $5.13 million in Standard BioTools stock - Investing.com
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock - Investing.com
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Biochips Market Generated Opportunities, Future Scope 2025-2032 | PerkinElmer, Inc., Fluidigm Corporation, Illumina - openPR
Q1 Earnings Forecast for Standard BioTools Issued By KeyCorp - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Simply Wall St
ARK Investment Management LLC Lowers Stake in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools to Participate in Upcoming Investor Conferences -February 27, 2025 at 04:02 pm EST - Marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Quarterly Earnings Results, Hits Estimates - MarketBeat
Standard BioTools Inc. Faces Revenue Decline Amid Market Challenges - TipRanks
Standard BioTools cut to Neutral at KeyBanc on guidance - MSN
Standard BioTools to Participate in Upcoming Investor Conferences - The Manila Times
Standard BioTools downgraded to Sector Weight from Overweight at KeyBanc - TipRanks
Standard BioTools Sets March Investor Conference Schedule: What Financial Updates Might Be Revealed? - StockTitan
Standard BioTools Shares Fall After Downgrade From KeyBanc -February 27, 2025 at 01:59 pm EST - Marketscreener.com
Standard BioTools stock downgraded at KeyBanc (LAB:NASDAQ) - Seeking Alpha
Standard BioTools Inc. (NASDAQ:LAB) Q4 2024 Earnings Call Transcript - Insider Monkey
KeyBanc Downgrades Standard BioTools to Sector Weight From Overweight, Removes $4 Price Target - Marketscreener.com
KeyBanc cuts Standard BioTools stock rating on revenue concerns - Investing.com India
KeyBanc cuts Standard BioTools stock rating on revenue concerns By Investing.com - Investing.com South Africa
Standard BioTools Inc (LAB) Q4 2024 Earnings Call Highlights: Na - GuruFocus.com
Standard BioTools Inc (LAB) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Standard BioTools: Q4 Earnings Snapshot - CTPost
Standard BioTools reports Q4 EPS (9c), consensus (3c) - TipRanks
Standard BioTools Reports 2024 Financial Results - TipRanks
Buy Rating for Standard BioTools: Balancing Challenges with Strategic Growth Initiatives - TipRanks
Standard BioTools: Q4 Earnings Snapshot -February 26, 2025 at 06:53 pm EST - Marketscreener.com
Earnings call transcript: Standard BioTools Q4 2024 misses forecasts, stock dips - Investing.com
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools Reports 2024 Financial Results and Strategic Outlook - TipRanks
Can Standard BioTools' Massive $90M Cost Cuts Offset Declining Revenue? - StockTitan
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Fluidigm stock hits 52-week low at $1.17 amid market challenges By Investing.com - Investing.com South Africa
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results -February 26, 2025 at 04:02 pm EST - Marketscreener.com
Fluidigm stock hits 52-week low at $1.17 amid market challenges - Investing.com
Shareholders in Standard BioTools (NASDAQ:LAB) have lost 66%, as stock drops 10.0% this past week - Yahoo Finance
Standard BioTools Inc (LAB) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Analysts review Standard BioTools Inc’s rating - Knox Daily
Standard BioTools (LAB) to Release Quarterly Earnings on Wednesday - MarketBeat
Market Cool On Standard BioTools Inc.'s (NASDAQ:LAB) Revenues Pushing Shares 28% Lower - Simply Wall St
Standard BioTools (NASDAQ:LAB) Stock Price Up 7.1%Here's What Happened - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 2,960,169 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools (NASDAQ:LAB) Hits New 52-Week LowTime to Sell? - MarketBeat
Taking a look at what insiders are doing to gauge the Standard BioTools Inc (LAB)’s direction - Knox Daily
Fluidigm stock hits 52-week low at $1.21 amid market challenges - MSN
Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025 - GlobeNewswire
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):